Vitamin D, Gut Microbiota, and Cancer Immunotherapy—A Potentially Effective Crosstalk
International Journal of Molecular Sciences · 22.07.2025 · 26 (15) · 7052
DOI: 10.3390/ijms26157052 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 22.07.2025. Verfasst von Yizhen Yan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Key Laboratory of Sports Performance and Skill Assessment, Beijing Sport University, Beijing 100084, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Vitamin D, Immunotherapy, Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The National Key R&D Program of China (No. 2022YFC3600201), Chinese Universities Scientific Fund (No. 2024JNPD001)., National Key R&D Program of China.
Abstract (Originalsprache)
Recent breakthroughs in cancer immunotherapy have shown remarkable success, yet treatment efficacy varies significantly among individuals. Emerging evidence highlights the gut microbiota as a key modulator of immunotherapy response, while vitamin D (VD), an immunomodulatory hormone, has garnered increasing attention for its potential interactions with gut microbiota and immunotherapy outcomes. However, the precise mechanisms and clinical applications of VD in this context remain controversial. This study systematically analyzed peer-reviewed evidence from PubMed, Scopus, Web of Science, PsycINFO, and MEDLINE (January 2000–May 2025) to investigate the complex interplay among VD, gut microbiota, and cancer immunotherapy. This review demonstrates that VD exerts dual immunomodulatory effects by directly activating immune cells through vitamin D receptor (VDR) signaling while simultaneously reshaping gut microbial composition to enhance antitumor immunity. Clinical data reveal paradoxical outcomes: optimal VD levels correlate with improved immunotherapy responses and reduced toxicity in some studies yet are associated with immunosuppression and poorer survival in others. The bidirectional VD–microbiota interaction further complicates this relationship: VD supplementation enriches beneficial bacteria, which reciprocally regulate VD metabolism and amplify immune responses, whereas excessive VD intake may disrupt this balance, leading to dysbiosis and compromised therapeutic efficacy. These findings underscore the need to elucidate VD’s dose-dependent and microbiota-mediated mechanisms to optimize its clinical application in immunotherapy regimens. Future research should prioritize mechanistic studies of VD’s immunoregulatory pathways, personalized strategies accounting for host–microbiota variability, and large-scale clinical trials to validate VD’s role as an adjuvant in precision immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Beijing Key Laboratory of Sports Performance and Skill Assessment, Beijing Sport University, Beijing 100084, China.
- School of Sports Medicine and Rehabilitation, Beijing Sport University, Beijing 100084, China.
Förderung
- The National Key R&D Program of China (No. 2022YFC3600201)
- Chinese Universities Scientific Fund (No. 2024JNPD001).
- National Key R&D Program of China
- Chinese Universities Scientific Fund
Zitieren
APA
Yan, Y., Guo, Y., Li, Y., Jiang, Q., Yuan, C., Zhao, L., & Mao, S. (2025). Vitamin D, Gut Microbiota, and Cancer Immunotherapy—A Potentially Effective Crosstalk. International Journal of Molecular Sciences, 26(15), 7052. https://doi.org/10.3390/ijms26157052
Vancouver
Yan Y, Guo Y, Li Y, Jiang Q, Yuan C, Zhao L, et al. Vitamin D, Gut Microbiota, and Cancer Immunotherapy—A Potentially Effective Crosstalk. International Journal of Molecular Sciences. 2025;26(15):7052. doi:10.3390/ijms26157052
BibTeX
@article{Yan2025,
author = {Yan, Yizhen and Guo, Yi and Li, Yiting and Jiang, Qingrui and Yuan, Chenhang and Zhao, Li and Mao, Shanshan},
title = {Vitamin D, Gut Microbiota, and Cancer Immunotherapy—A Potentially Effective Crosstalk},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {15},
pages = {7052},
doi = {10.3390/ijms26157052}
}
EUVIMED